Addex Therapeutics (ADXN) Interest & Investment Income (2019 - 2025)
Addex Therapeutics (ADXN) posted Interest & Investment Income of $3.62 for Q2 2025, down 99.98% sequentially from $19879.6 in Q4 2024, and up 100.01% YoY from $1.81 in Q2 2024.
Addex Therapeutics (ADXN) Interest & Investment Income (2019 - 2025) Analysis & Trends
Addex Therapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $3.62 in Q2 2025.
- Quarterly Interest & Investment Income rose 100.01% year-over-year to $3.62 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$30049.5 (down 147.68% YoY) and the FY2024 annual result came in at $30230.6, down 58.08% from the prior year.
- Interest & Investment Income fell to $3.62 in Q2 2025 per ADXN's latest filing, from $19879.6 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $585276.7 in Q1 2021 and troughed at -$176091.9 in Q2 2021.
- A 5-year average of $22191.6 and a median of $3731.8 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2023: Interest & Investment Income slumped 10965.38% in 2021, then soared 24941.88% in 2023.
- Over 5 years, Interest & Investment Income stood at -$150956.2 in 2021, then surged by 117.43% to $26310.7 in 2022, then tumbled by 43.74% to $14803.3 in 2023, then surged by 34.29% to $19879.6 in 2024, then tumbled by 99.98% to $3.62 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $3.62, $19879.6, and -$21367.8 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -3,393.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.62 |
| Dec 31, 2024 | 19,879.60 |
| Sep 30, 2024 | -21,367.84 |
| Jun 30, 2024 | -28,564.86 |
| Mar 31, 2024 | 61,322.65 |
| Dec 31, 2023 | 14,803.29 |
| Sep 30, 2023 | 15,462.94 |
| Jun 30, 2023 | 14,846.43 |
| Mar 31, 2023 | 25,759.78 |
| Dec 31, 2022 | 26,310.74 |
| Sep 30, 2022 | 3,731.79 |
| Jun 30, 2022 | 212.85 |
| Mar 31, 2022 | 102.87 |
| Dec 31, 2021 | -150,956.18 |
| Sep 30, 2021 | -13,475.79 |
| Jun 30, 2021 | -176,091.92 |
| Mar 31, 2021 | 585,276.68 |
| Dec 31, 2020 | 1,389.33 |
| Sep 30, 2020 | 1,390.55 |
| Jun 30, 2020 | 11,252.99 |